Nurture creative people, build great teams and encourage innovative ideas
Nicholas Franano, MD, is a physician, scientist, inventor, and entrepreneur. He is President and CEO of Artio Medical, and a co-founder. Dr. Franano is an experienced entrepreneur, founding several companies including Artio Medical, Flow Forward Medical, Novita Therapeutics, and Proteon Therapeutics (NYSE: PRTO). Dr. Franano has held positions of President, CEO, and CSO at these companies, which have raised collectively over $120 million in capital and grants.
Before Proteon, Dr. Franano maintained an active clinical practice in interventional radiology, performing a wide range of vascular and non-vascular procedures. He received both his Doctor of Medicine and Master of Science in biomedical research from Washington University in St. Louis. He completed a residency in Diagnostic Radiology and a fellowship in Interventional Radiology at Johns Hopkins Hospital. He has received numerous research awards, grants and fellowships, and has published many abstracts and articles in peer-reviewed journals.
Dr. Franano holds 11 patents and more than 30 pending patent applications. In 2009, Dr. Franano was named a “Technology Pioneer” by the World Economic Forum and an Ernst & Young “Entrepreneur of the Year” for the Central Midwest. Dr. Franano serves on the Biological Sciences Advisory Board at the University of Kansas and the Entrepreneurship Council at Washington University in St. Louis.